- Home
- INHD vs CLNN Comparison
INHD vs CLNN Comparison
Compare INHD & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INHD | CLNN |
|---|---|---|
| Founded | 2019 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.1M | 120.6M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | INHD | CLNN |
|---|---|---|
| Price | $0.14 | $6.76 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $32.67 |
| AVG Volume (30 Days) | ★ 52.3M | 315.5K |
| Earning Date | 12-09-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,645,845.00 | $214,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $87.58 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 787.64 | N/A |
| 52 Week Low | $0.12 | $2.28 |
| 52 Week High | $19.78 | $13.50 |
Technical Indicators
Market Signals| Indicator | INHD | CLNN |
|---|---|---|
| Relative Strength Index (RSI) | 20.25 | 40.52 |
| Support Level | $0.14 | $5.42 |
| Resistance Level | $0.16 | $7.03 |
| Average True Range (ATR) | 0.27 | 0.97 |
| MACD | 0.02 | -0.23 |
| Stochastic Oscillator | 0.70 | 24.91 |
Price Performance
Historical ComparisonAbout INHD Inno Holdings Inc.
Inno Holdings Inc is a building technology company with a mission to transform the construction industry with its proprietary cold-formed steel-framing technology and other innovations. It is a manufacturer of cold-formed-steel members and prefabricated homes. It offers a full range of services required to transform raw materials into precise steel framing products and prefabricated homes. The company sells these finished products either to businesses or directly to customers. The finished products and cold-formed-steel members are used in a variety of building types, including residential, commercial, industrial and infrastructure.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.